Cargando…
A Potent and Selective Peptide Blocker of the Kv1.3 Channel: Prediction from Free-Energy Simulations and Experimental Confirmation
The voltage-gated potassium channel Kv1.3 is a well-established target for treatment of autoimmune diseases. ShK peptide from a sea anemone is one of the most potent blockers of Kv1.3 but its application as a therapeutic agent for autoimmune diseases is limited by its lack of selectivity against oth...
Autores principales: | Rashid, M. Harunur, Heinzelmann, Germano, Huq, Redwan, Tajhya, Rajeev B., Chang, Shih Chieh, Chhabra, Sandeep, Pennington, Michael W., Beeton, Christine, Norton, Raymond S., Kuyucak, Serdar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820677/ https://www.ncbi.nlm.nih.gov/pubmed/24244345 http://dx.doi.org/10.1371/journal.pone.0078712 |
Ejemplares similares
-
A potent and Kv1.3-selective analogue of the scorpion toxin HsTX1 as a potential therapeutic for autoimmune diseases
por: Rashid, M. Harunur, et al.
Publicado: (2014) -
Development of Highly Selective Kv1.3-Blocking Peptides Based on the Sea Anemone Peptide ShK
por: Pennington, Michael W., et al.
Publicado: (2015) -
Computational Study of the Loss-of-Function
Mutations in the Kv1.5 Channel Associated with Atrial Fibrillation
por: Rashid, Md Harunur, et al.
Publicado: (2018) -
Distribution and kinetics of the Kv1.3-blocking peptide HsTX1[R14A] in experimental rats
por: Bergmann, Ralf, et al.
Publicado: (2017) -
Molecular Dynamics Simulations of the Mammalian Glutamate Transporter EAAT3
por: Heinzelmann, Germano, et al.
Publicado: (2014)